Meptazinol Hydrochloride, bearing the CAS number 59263-76-2, is a compound of notable interest within the pharmaceutical and chemical research communities. Its primary application lies in its role as an analgesic, specifically for managing moderate to severe pain. The mechanism of action is multifaceted, involving partial agonism at mu-1 opioid receptors, which distinguishes it from many other opioid analgesics. This specific interaction profile is often associated with a potentially more favorable side-effect profile, particularly concerning respiratory depression.

Furthermore, Meptazinol Hydrochloride exhibits inhibitory activity against acetylcholinesterase. This enzymatic inhibition is a key characteristic that expands its research utility, offering avenues for studying cholinergic pathways and developing treatments for neurological conditions. The compound's physical form as a white solid with a defined melting point (around 250-252°C) and its solubility characteristics are crucial parameters for its handling and formulation in various research and development settings.

The Meptazinol Hydrochloride properties are well-documented, making it a reliable choice for researchers. Whether used as an active pharmaceutical ingredient in specific formulations or as a critical pharmaceutical intermediate, its purity and consistent quality are paramount. Understanding the full spectrum of Meptazinol Hydrochloride CAS 59263-76-2 properties allows for its effective utilization in diverse scientific applications, from pain management research to the synthesis of new chemical entities. We provide this essential compound to support your vital research objectives.